Hard To Treat Diseases released an announcement today that it was going forward with its share buyback program. The program will be financed using money generated from the sales of some of the company's disposable assets. According to the press release at minamargroup.net, the objectives of Hard To Treat Diseases are to buy back 500 million shares of the company's float (unrestricted shares of issued stock) in an effort to raise the value of the company security.

By reducing the float through the share buyback program, remaining shares outstanding should experience an increase in volatility. This rings as good news for shareholders since volatility is an essential element in generating price movement, especially with stocks priced in the sub-penny range.

The press release announcing the company's decision to go forward with the share buyback program can be read at
http://minamarmarketinggroup.helpserve.com/index.php?_m=news&_a=viewnews&newsid=194

Tags: HTDS

Bookmark: